Ray, A
Das, D S
Song, Y
Macri, V
Richardson, P
Brooks, C L
Chauhan, D
Anderson, K C
Article History
Received: 20 December 2016
Revised: 17 March 2017
Accepted: 20 April 2017
First Online: 8 May 2017
Competing interests
: KCA is on Advisory board of Celgene, Millenium, Gilead and Bristol Myers Squibb, and is a Scientific Founder of Acetylon, Oncopep, and C4 Therapeutics. DC is consultant to Stemline Therapeutic, Inc. The remaining authors declare no conflict of interest.